Lignans from Euphorbia hirta L

Nat Prod Res. 2022 Jan;36(1):26-36. doi: 10.1080/14786419.2020.1761358. Epub 2020 May 6.

Abstract

Five new lignans, euphorhirtins A-D (1-4), 5-methoxyvirgatusin (5), three artefacts, 7S-ethoxyisolintetralin (6), 7R-ethoxyisolintetralin (7), and 7R-ethoxy-3-methoxyisolintetralin (8), together with 13 known ones (9-21) were isolated from the medicinal plant Euphorbia hirta L. The structures of the compounds were elucidated by means of extensive spectroscopic analysis, including 1D and 2D NMR and HR-ESI-MS experiments. The absolute configurations of compound 1 was determined by ECD calculation. The isolates were evaluated for their inhibitory effects against the proliferation of the cancer cell lines (Hep G2, A549, and DU145) and compounds 14 and 18 showed inhibitory activity against the Hep G2 cells with IC50 values 7.2 ± 0.17 and 8.5 ± 0.36 μM.

Keywords: Anti-proliferative activity; ECD calculation; Euphorbia hirta L.; HR-ESI-MS; Lignans; NMR.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents, Phytogenic* / pharmacology
  • Euphorbia* / chemistry
  • Hep G2 Cells
  • Humans
  • Lignans* / pharmacology
  • Molecular Structure
  • Plant Extracts / pharmacology

Substances

  • Antineoplastic Agents, Phytogenic
  • Lignans
  • Plant Extracts